Stem Cell Markets

Stem Cell Markets

A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ injuries, including cardiovascular disease, neurological disease, musculoskeletal disease, diabetes and hematopoietic disorders. Stem cell fate is determined by both intrinsic regulators and the extra-cellular environment (niche), and their expansion and differentiation ex vivo are generally controlled by growing them in a specific configuration (monolayer or three-dimensional culture). This process, which is vital to enable stem cells to be used for therapeutic purposes, is called differentiation. Differentiation is a process involving unspecialized cells progressing to become specialized cells with restricted developmental potential. The purpose of this TriMark Publications report is to describe the specific market segments of the medical research space using stem cells for research and development (R&D) purposes. This study reviews all of the generally accepted analytical methods that are currently in use today for preparing and using stem cells. It examines the use of stem cells in developing new therapies for disease.

2.3.1 Neural and Neuronal Differentiation

2.3.2 Cardiomyogenic Differentiation of ESCs

2.3.3 Differentiation of Mesenchymal Stem/Progenitor Cells

3.3.1 Cord Blood Stem Cells and Cord Blood Stem Cell Banking: Current Market Environment and Opportunity

3.4.1 Characteristics of the Respondent Pool

3.4.2 Utilization of the Different Classes of Stem Cells

3.4.3 Quantitative Metrics of the Stem Cell Research Marketplace: Number of Experiments Performed in Research

3.4.4 Evolution of Research Activities with the Different Types of Stem Cells: Current Usage Trends and Usage in 12 to 18 Months

3.4.5 Types of Research Activities the End-User Community Performs with the Different Types of Stem Cells

3.4.6 Challenges Facing Stem Cell Researchers

3.4.7 Market Drivers and Research Questions Being Addressed in the Stem Cell Space

3.4.8 Summary of Challenges and Opportunities in the Stem Cell Space Based on TriMark’s Analysis

3.4.9 Unmet Product Needs in the Stem Cell Research Space and Licensing/IP Constraints

3.5.1 SWOT Analysis of the Major Stem Cell Market Segments

4.2.1 Top Research Institutions Worldwide in the Stem Cells Space and Global “Hot Spots” for Research and Therapeutics

4.3.1 Proposition 71 in the State of California

4.5.1 U.S. Government Policy on Stem Cell Research

4.5.2 Current Federal Policy

4.5.2.1 Moral Issues Affecting the Policy

4.5.2.2 Significance and Requirement of Federal Funding

4.5.2.3 Implementing the Current Policy

4.5.3 International Law

4.5.3.1 Australia

4.5.3.2 U.K.

4.5.3.3 Canada

4.5.3.4 China

4.5.3.5 Germany

4.5.3.6 Switzerland

4.5.3.7 Japan

4.5.3.8 Israel

4.5.3.9 Singapore

4.5.4 Technological and Economical Disadvantage for U.S.

5.2.1 Hematopoietic Stem Cells (HSCs)

5.2.2 Stem Cell Therapeutics for Cardiac and Ischemic Diseases

5.2.3 Stem Cell Therapeutics for Type I Diabetes

5.2.4 Stem Cell Therapeutics for Orthopedic Diseases

5.2.5 Stem Cell Therapeutics for Neurological Disease